97923896 - ELEVIDYS

Information

• Trademark
• 97923896

• Source

• Serial Number

  97923896

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  May 06, 2023
  a year ago

• Transaction Date

  May 22, 2024
  9 days ago

• Status Date

  May 22, 2024
  9 days ago

• Location Date

  February 06, 2024
  3 months ago

• Status Code

  602

• Current Location

  TMO LAW OFFICE 115 - EXAMINING ATTORNEY ASSIGNED

  Employee Name

  CHANG, ELIZABETH YI HS

• Attorney Name

  Maury M. Tepper, III

  Law Office Assigned Location Code

  M60

• Owners

  • SAREPTA THERAPEUTICS, INC.

Case File Statements

• DM0000: The mark consists of three alternately-shaded semicircles increasing in size to an oval center and three alternately-shaded semicircles decreasing in size on the other side of the oval center and followed by 'Elevidys.' The color gray is intended to show shading or contrast only.
• GS0051: Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapies for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
• CC0000: Color is not claimed as a feature of the mark.

Case File Event Statements

• 5/10/2023 - a year ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 6/5/2023 - 12 months ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 6/6/2023 - 12 months ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 1/31/2024 - 4 months ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 2/6/2024 - 3 months ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 2/6/2024 - 3 months ago

  6 - NON-FINAL ACTION E-MAILED Type: GNRT

• 2/6/2024 - 3 months ago

  7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 5/22/2024 - 9 days ago

  9 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Type: MAB2

• 5/22/2024 - 9 days ago

  8 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2